QUREuniQure N.V.

QURE Stock Price, Valuation & Chart | uniQure N.V.

Compare

$46.230-1.63 (-3.41%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology QURE intrinsic value QURE calculated fair value vs price

Overview Financials Dividends Ratios

QURE Historical price chart

QURE Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization3.21B

PE Ratio-11.53

EPS-4.01

Trading Volume2.48M

Today's High/Low50.97/45.25

Dividend Yield0.00

52 Week High/Low71.5/8.73

Shares Outstanding69.37M

QURE Financial Statement

QURE Analyst ratings

QURE Analysis & performance metrics

QURE Company profile

uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is…

uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the…

QURE Management team

Name

Position

Erin Boyer

Chief People & Culture Officer

Hugo KatusCEO

Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany

Christian KlemtCFO

Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site

Jeannette Potts J.D., Ph.D.

Chief Legal & Compliance Officer and Corporate Secretary

Amin Abujoub Ph.D.

Chief Technical Operations Officer

Matthew Craig Kapusta CPACEO

Chief Executive Officer & Executive Director

Tamara Tugal Ph.D., MBACTO

Business Development Director

Walid Abi-Saab M.D.

Chief Medical Officer

Name

Position

Erin Boyer

Chief People & Culture Officer

Hugo KatusCEO

Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany

Christian KlemtCFO

Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site

Jeannette Potts J.D., Ph.D.

Chief Legal & Compliance Officer and Corporate Secretary

Amin Abujoub Ph.D.

Chief Technical Operations Officer

Matthew Craig Kapusta CPACEO

Chief Executive Officer & Executive Director

Tamara Tugal Ph.D., MBACTO

Business Development Director

Walid Abi-Saab M.D.

Chief Medical Officer

Management Team

Erin Boyer

Chief People & Culture Officer

Hugo KatusCEO

Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany

Christian KlemtCFO

Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site

Jeannette Potts J.D., Ph.D.

Chief Legal & Compliance Officer and Corporate Secretary

Amin Abujoub Ph.D.

Chief Technical Operations Officer

Matthew Craig Kapusta CPACEO

Chief Executive Officer & Executive Director

Tamara Tugal Ph.D., MBACTO

Business Development Director

Walid Abi-Saab M.D.

Chief Medical Officer

Management

Erin Boyer

Chief People & Culture Officer

Hugo KatusCEO

Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany

Christian KlemtCFO

Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site

Jeannette Potts J.D., Ph.D.

Chief Legal & Compliance Officer and Corporate Secretary

Amin Abujoub Ph.D.

Chief Technical Operations Officer

Matthew Craig Kapusta CPACEO

Chief Executive Officer & Executive Director

Tamara Tugal Ph.D., MBACTO

Business Development Director

Walid Abi-Saab M.D.

Chief Medical Officer

Total 8 executives

QURE Frequently asked questions

What is uniQure N.V. (QURE) Stock Price?

Current stock price of uniQure N.V. (QURE) stock is $46.230. The stock price is -3.41% lower in the session. The intraday range can be seen from this page. Volume of uniQure N.V. (QURE) stock is 2.48M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the uniQure N.V. (QURE) stock price going up or down today?

The stock price of uniQure N.V. (QURE) can change with earnings, company news, and overall market sentiment. uniQure N.V. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the uniQure N.V. stock expensive at its current price?

Whether uniQure N.V. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for QURE on this page is -11.53. EPS on this page is -4.01. Compare those figures with peers and growth expectations before deciding if the current uniQure N.V. price is justified.

How has the stock price of uniQure N.V. (QURE) performed historically?

Historical performance for uniQure N.V. (QURE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how QURE reacted to past earnings and market events.

Should I buy uniQure N.V. (QURE) stock, at this price?

Buying uniQure N.V. (QURE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.